Evaluation of Upadacitinib Efficacy in the Treatment of Atopic Dermatitis of Sensitive Areas
Our study demonstrates a significant benefit for patients with AD affecting sensitive areas when treated with upadacitinib, supporting its use first-line therapeutic choice for this specific subset of patients.
Authors
- Giovanni Pellacani (ORCID: https://orcid.org/0000-0002-7222-2951)
- Luca Bianchi (ORCID: https://orcid.org/0000-0001-8697-6896)
- Filomena Russo (ORCID: https://orcid.org/0000-0003-2780-7720)
- Flavia Pigliacelli (ORCID: https://orcid.org/0000-0003-2118-0795)
- Andrea Chiricozzi (ORCID: https://orcid.org/0000-0002-6739-0387)
- Niccolò Gori (ORCID: https://orcid.org/0000-0003-1987-0623)
- Claudia Paganini
- Teresa Grieco (ORCID: https://orcid.org/0000-0001-7855-6621)
- Marina Talamonti (ORCID: https://orcid.org/0000-0002-3070-4071)
- Barbara Cocuroccia
- Marco Galluzzo (ORCID: https://orcid.org/0000-0002-3424-5175)
- Camilla Chello (ORCID: https://orcid.org/0000-0002-3142-1831)
- Giacomo Caldarola (ORCID: https://orcid.org/0000-0002-8837-9232)
- Flaminia Antonelli (ORCID: https://orcid.org/0000-0002-5283-2859)
- Clara De Simone (ORCID: https://orcid.org/0000-0002-0898-0045)
- Ketty Peris (ORCID: https://orcid.org/0000-0002-5237-0463)
- Domenico Giordano (ORCID: https://orcid.org/0000-0003-0624-2097)
- Ersilia Tolino (ORCID: https://orcid.org/0000-0001-7861-9338)
- Annamaria Mazzotta
- Luisa Boeti (ORCID: https://orcid.org/0009-0001-1290-0474)
Institutions
- Università Cattolica del Sacro Cuore (IT)
- University of Rome Tor Vergata (IT)
- Agostino Gemelli University Polyclinic (IT)
- IRCCS San Camillo Hospital (IT)
- Policlinico Tor Vergata (IT)
- San Gallicano Hospital (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Ospedale generale di zona San Camillo Treviso (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Dermatology
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1159/000545227
- Citations
- 4
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 8.02